Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ohtake

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Leukemia|September 16, 2017
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSGT Sakura, F Hayakawa, I Sugiura, et al.
Blood Cancer Journal|October 18, 2014
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study GroupF Hayakawa, T Sakura, T Yujiri, et al.
Leukemia Research|August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study GroupK Ohnishi, M Tomonaga, N Kamada, et al.
Leukemia|July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 studyJ Takeuchi, T Kyo, K Naito, et al.
International Journal of Hematology|September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study GroupS Miyawaki, M Tanimoto, T Kobayashi, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
Blood Cancer Journal|April 29, 2017
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemiaE Togasaki, J Takeda, K Yoshida, et al.
Leukemia|February 4, 2014
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patientsR Kihara, Y Nagata, H Kiyoi, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Leukemia|September 16, 2017
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSGT Sakura, F Hayakawa, I Sugiura, et al.
Blood Cancer Journal|October 18, 2014
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study GroupF Hayakawa, T Sakura, T Yujiri, et al.
Leukemia Research|August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study GroupK Ohnishi, M Tomonaga, N Kamada, et al.
Leukemia|July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 studyJ Takeuchi, T Kyo, K Naito, et al.
International Journal of Hematology|September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study GroupS Miyawaki, M Tanimoto, T Kobayashi, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
Blood Cancer Journal|April 29, 2017
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemiaE Togasaki, J Takeda, K Yoshida, et al.
Leukemia|February 4, 2014
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patientsR Kihara, Y Nagata, H Kiyoi, et al.
Pageof 22